Clinical trial

Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal…

NCT00374647 · University of Cincinnati, Other · Completed

Key facts

NCT number NCT00374647
Title Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts
Official title Open Label Randomized Single Study to Evaluate the Safety & Efficacy of Early CNI Withdrawal in Recipients of Primary Renal Allografts Maintained Long-Term on Mycophenolate Mofetil; MMF (CellCept) and Sirolimus (Rapamune)
Lead sponsor University of Cincinnati, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Primary Renal Allograft
Intervention type Drug
Interventions mycophenolate mofetil, sirolimus
Enrollment 17
Start date Mar 1, 2005
Primary completion Dec 1, 2007
Completion Dec 1, 2007
First posted Sep 11, 2006
Last update posted Jul 15, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies